The discrepancy in serum AMH levels between our study and these other publications may be due to differences in the participants’ age, number of cases, thyroid status and thyroid disease duration (in the AIT groups), and type of medication used for therapy since thyroxine treatment may relieve all the adverse factors associated with high TSH and thyroid antibodies and restore the ovarian function (19). The gene discussed is AMH; the disease is thyroid gland disorder.